logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales

Lessler J, Moore SM, Luquero FJ, McKay H, Grais RF,  et al.
2018-05-01 • Lancet
2018-05-01 • Lancet
Cholera remains a persistent health problem in sub-Saharan Africa and worldwide. Cholera can be controlled through appropriate water and sanitation, or by oral cholera vaccination, which...
Journal Article
|
Short Report

Continuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013

Gamougam K, Daugla DM, Toralta J, Ngadoua C, Fermon F,  et al.
2015-01-01 • Emerging Infectious Diseases
2015-01-01 • Emerging Infectious Diseases
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated...
Journal Article
|
Research

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial

Daugla DM, Gami JP, Gamougam K, Naibei N, Mbainadji L,  et al.
2014-01-04 • Lancet
2014-01-04 • Lancet
A serogroup A meningococcal polysaccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safe...